CATALOGO DEI PRODOTTI DELLA RICERCA

BENEDETTI, MARIADONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.629
EU - Europa 4.860
AS - Asia 3.389
SA - Sud America 428
AF - Africa 79
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.553
RU - Federazione Russa 1.817
SG - Singapore 1.263
CN - Cina 1.212
GB - Regno Unito 998
IT - Italia 473
SE - Svezia 392
BR - Brasile 331
FR - Francia 281
HK - Hong Kong 268
VN - Vietnam 259
FI - Finlandia 235
DE - Germania 219
IE - Irlanda 209
KR - Corea 104
UA - Ucraina 67
IN - India 54
TR - Turchia 40
CA - Canada 37
AR - Argentina 36
JP - Giappone 33
BE - Belgio 29
MX - Messico 23
PL - Polonia 22
IQ - Iraq 20
NL - Olanda 20
ZA - Sudafrica 20
BD - Bangladesh 19
ES - Italia 17
ID - Indonesia 16
NG - Nigeria 16
EC - Ecuador 15
SA - Arabia Saudita 14
PY - Paraguay 13
AT - Austria 12
CL - Cile 12
IR - Iran 12
UZ - Uzbekistan 12
IL - Israele 11
CZ - Repubblica Ceca 10
AU - Australia 9
CH - Svizzera 9
CO - Colombia 9
MA - Marocco 9
PK - Pakistan 9
DK - Danimarca 8
GR - Grecia 7
JO - Giordania 7
DO - Repubblica Dominicana 6
EU - Europa 6
LT - Lituania 6
VE - Venezuela 6
AZ - Azerbaigian 5
DZ - Algeria 5
PH - Filippine 5
TN - Tunisia 5
EG - Egitto 4
LV - Lettonia 4
RO - Romania 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
MN - Mongolia 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
CI - Costa d'Avorio 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
TG - Togo 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
Totale 14.392
Salva come PNG Salva come JPEG
Città #
Southend 814
Singapore 707
Ashburn 658
Moscow 613
Chandler 611
San Jose 463
Dallas 445
Jacksonville 428
Woodbridge 410
Ann Arbor 301
Hong Kong 263
Dublin 209
Houston 193
Verona 193
Beijing 181
New York 147
The Dalles 120
Wilmington 97
Lawrence 89
Princeton 89
Nanjing 85
Los Angeles 84
Jinan 80
Helsinki 76
Hebei 74
Hanoi 65
Ho Chi Minh City 63
Shenyang 62
Buffalo 50
Orem 47
Tianjin 45
Munich 41
Haikou 40
Changsha 39
São Paulo 39
Boardman 37
Ningbo 37
Columbus 33
Milan 33
Santa Clara 33
Zhengzhou 32
Redondo Beach 30
Brussels 29
Taiyuan 28
Tokyo 28
Turku 28
Council Bluffs 27
Hangzhou 27
Lancaster 27
Washington 27
Nanchang 26
Taizhou 25
Fuzhou 24
Stockholm 24
Sindelfingen 22
Guangzhou 21
Istanbul 21
Bologna 20
Chennai 20
Redmond 20
Redwood City 20
Atlanta 18
Denver 18
Jiaxing 18
Seattle 18
Brooklyn 17
Warsaw 17
Frankfurt am Main 16
Norwalk 16
Abuja 15
Auburn Hills 15
Da Nang 15
London 15
Poplar 15
Falls Church 14
Lanzhou 14
Montreal 14
Rome 14
Johannesburg 13
Manchester 13
Belo Horizonte 12
Boston 12
Chicago 12
Düsseldorf 12
Haiphong 12
Seoul 12
Amsterdam 11
Clearwater 11
Paris 11
Phoenix 11
San Francisco 11
Tashkent 11
Baghdad 10
Dong Ket 10
Olomouc 10
Riva 10
Kemerovo 9
Toronto 9
Barnet 8
Buenos Aires 8
Totale 9.127
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 251
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 232
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 231
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 225
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 218
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 217
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 216
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 214
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 214
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 208
A case of acute fulminant multiple sclerosis treated with alemtuzumab 208
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 207
Cognitive onset in multiple sclerosis 204
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 204
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 202
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 201
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 201
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 200
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk 193
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 193
Apporto della neurofisiologia allo studio delle disfunzioni dell'apparato uro-genitale 189
Effects of pulsed electromagnetic fields on nerve regeneration: an experimental study in the rat 184
Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases 184
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 184
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 184
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 184
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 182
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial 182
Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immuno-cytochemical and morphometric study 179
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? 178
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 178
Epilepsy in multiple sclerosis: The role of temporal lobe damage 177
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. 174
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 173
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study 173
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. 171
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 171
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 170
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 170
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 169
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 168
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 168
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 166
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 163
A multicentric prospective incidence study of Guillain-Barré Syndrome in Italy. The ITANG Study 161
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 156
Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro 155
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. 153
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 151
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 147
Multifactorial etiological aspects of epilepsy 146
Epilessia ed imaging 146
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 146
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 145
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 145
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 143
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 142
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 142
Resting motor threshold in idiopathic generalized epilepsies: A systematic review with meta-analysis. 141
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 139
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 139
Azathioprine in multiple sclerosis 138
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 137
Prognosi del Piccolo Male-assenze tipiche. Studio di follow-up su 60 casi. [Prognosis of pure petit mal. Follow-up study of 60 cases] 137
Short term prognosis of stroke in a clinical series of 94 patients 136
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis 135
Long survival and clinical stability in Marburg's variant multiple sclerosis. 132
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study 129
Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long‐Term Course of Epilepsy 128
Prognostic factors of acute partial transverse myelitis. 127
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 125
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 125
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 124
Prevalence of dementia and apoliprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy 123
Use of plasma levels for antiepileptic drug monitoring in clinical practice 122
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 120
Efficacia della monoterapia in pazienti epilettici di nuova diagnosi e precedentemente non trattati. Studio prospettico 118
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study 117
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 117
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 115
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 112
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 106
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial 104
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 99
Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease 99
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 94
Trial of minocycline in clinically isolated syndrome of Multiple Sclerosis 94
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. 92
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 88
Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis 86
Totale 14.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.461
article - articoli 43.924
book - libri 0
conference - conferenze 521
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.016
Totale 90.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 35 92 44
2021/2022938 85 350 12 122 19 23 10 54 26 18 51 168
2022/20231.607 109 195 140 290 126 364 12 114 176 11 49 21
2023/2024860 30 72 83 85 101 195 26 78 6 33 90 61
2024/20251.832 95 128 104 288 111 71 93 72 252 97 152 369
2025/20265.655 408 266 486 920 1.574 372 531 265 511 322 0 0
Totale 14.502